Moroi Rintaro, Nochioka Kotaro, Miyata Satoshi, Iwaki Hideya, Chiba Hirofumi, Nagai Hiroshi, Shimoyama Yusuke, Naito Takeo, Shiga Hisashi, Tosa Masaki, Kakuta Yoichi, Kayaba Shoichi, Takahashi Seiichi, Kinouchi Yoshitaka, Masamune Atsushi
Division of Gastroenterology Tohoku University Hospital Miyagi Japan.
Clinical Research Innovation and Education Center Tohoku University Hospital Miyagi Japan.
DEN Open. 2024 Sep 3;5(1):e70002. doi: 10.1002/deo2.70002. eCollection 2025 Apr.
Radial incision and cutting (RIC) is being investigated as an alternative endoscopic dilation method for lower intestinal tract stenosis, providing a high technical success rate and improving subjective symptoms. However, several patients develop re-stenosis following RIC. In this pilot study, we aimed to evaluate the safety and efficacy of triamcinolone acetonide (TA) addition after RIC.
RIC with TA was performed in 20 patients with lower gastrointestinal tract stenosis. We evaluated the rate of adverse events 2 months after RIC with TA. We investigated the short- and long-term prognoses, as well as the improvement in subjective symptoms, using a visual analog scale.
The delayed bleeding rate after RIC was 23.8%. Endoscopic hemostasis was achieved in all patients with delayed bleeding. No perforations were observed. The cumulative re-stenosis-free, re-intervention-free, and surgery-free rates 1 year after RIC were 52.9%, 63.7%, and 85.2%, respectively. Subjective symptoms, including abdominal pain, abdominal bloating, nausea, and dyschezia, significantly improved after RIC with TA.
Although additional TA administration after RIC could be safe, additional TA may not be effective on luminal patency after dilation. Further investigation is warranted.
径向切开与切割术(RIC)作为一种用于治疗下肠道狭窄的替代内镜扩张方法正在接受研究,该方法具有较高的技术成功率且能改善主观症状。然而,有几位患者在RIC术后出现了再狭窄。在这项前瞻性研究中,我们旨在评估RIC术后添加曲安奈德(TA)的安全性和有效性。
对20名下胃肠道狭窄患者实施了RIC联合TA治疗。我们评估了RIC联合TA治疗2个月后的不良事件发生率。我们使用视觉模拟量表调查了短期和长期预后情况以及主观症状的改善情况。
RIC术后延迟出血率为23.8%。所有延迟出血患者均实现了内镜止血。未观察到穿孔情况。RIC术后1年的累积无再狭窄、无再次干预和无手术率分别为52.9%、63.7%和85.2%。包括腹痛、腹胀、恶心和排便困难在内的主观症状在RIC联合TA治疗后有显著改善。
虽然RIC术后额外给予TA可能是安全的,但额外给予TA可能对扩张后的管腔通畅性无效。有必要进行进一步研究。